Transcription of HIV: Tat and Cellular Chromatin

Advances in Pharmacology

Volumn 55, Issue , 2007, Pages 137-159

  Gatignol, Anne ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN;

CHEMISTRY; CHROMATIN; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; METABOLISM; REVIEW; VIRUS DNA CELL DNA INTERACTION;

CHROMATIN; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HIV; HUMANS; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION;

EID: 34250330779     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(07)55004-0     Document Type: Review

References (134)

1. Agbottah E., Deng L., Dannenberg L.O., Pumfery A., and Kashanchi F. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription. Retrovirology 3 (2006) 48
2. Ammosova T., Berro R., Kashanchi F., and Nekhai S. RNA interference directed to CDK2 inhibits HIV-1 transcription. Virology 341 (2005) 171-178
3. Ariumi Y., Serhan F., Turelli P., Telenti A., and Trono D. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription. Retrovirology 3 (2006) 47
4. Bannwarth S., and Gatignol A. HIV-1 TAR RNA: The target of molecular interactions between the virus and its host. Curr. HIV Res. 3 (2005) 61-71
5. Barboric M., and Peterlin B.M. A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation. PLoS Biol. 3 (2005) e76
6. Battisti P.-L., Daher A., Bannwarth S., Voortman J., Peden K.W.C., Hiscott J., Mouland A.J., Benarous R., and Gatignol A. Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells. AIDS Res. Hum. Retroviruses 19 (2003) 767-778
7. Becker P.B., and Horz W. ATP-dependent nucleosome remodeling. Annu. Rev. Biochem. 71 (2002) 247-273
8. Bedford M.T., and Richard S. Arginine methylation an emerging regulator of protein function. Mol. Cell 18 (2005) 263-272
9. Benkirane M., Chun R.F., Xiao H., Ogryzko V.V., Howard B.H., Nakatani Y., and Jeang K.T. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273 (1998) 24898-24905
10. Bieniasz P.D., Grdina T.A., Bogerd H.P., and Cullen B.R. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17 (1998) 7056-7065
11. Boulanger M.C., Liang C., Russell R.S., Lin R., Bedford M.T., Wainberg M.A., and Richard S. Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J. Virol. 79 (2005) 124-131
12. Bourgeois C.F., Kim Y.K., Churcher M.J., West M.J., and Karn J. Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences. Mol. Cell. Biol. 22 (2002) 1079-1093
13. Brady J., and Kashanchi F. Tat gets the "green" light on transcription initiation. Retrovirology 2 (2005) 69
14. Brand S.R., Kobayashi R., and Mathews M.B. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272 (1997) 8388-8395
15. Bres V., Kiernan R., Emiliani S., and Benkirane M. Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication. J. Biol. Chem. 277 (2002) 22215-22221
16. Bres V., Tagami H., Peloponese J.M., Loret E., Jeang K.T., Nakatani Y., Emiliani S., Benkirane M., and Kiernan R.E. Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J. 21 (2002) 6811-6819
17. Bres V., Kiernan R.E., Linares L.K., Chable-Bessia C., Plechakova O., Treand C., Emiliani S., Peloponese J.M., Jeang K.T., Coux O., Scheffner M., and Benkirane M. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat. Cell Biol. 5 (2003) 754-761
18. Brigati C., Giacca M., Noonan D.M., and Albini A. HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol. Lett. 220 (2003) 57-65
19. Bukrinsky M. SNFing HIV transcription. Retrovirology 3 (2006) 49
20. Bukrinsky M.I., and Haffar O.K. HIV-1 nuclear import: In search of a leader. Front. Biosci. 4 (1999) D772-D781
21. Cai R., Carpick B., Chun R.F., Jeang K.-T., and Williams B.R. HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch. Biochem. Biophys. 373 (2000) 361-367
22. Chen D., and Zhou Q. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase. Mol. Cell. Biol. 19 (1999) 2863-2871
23. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess Jr. J.W., Sowder II R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., et al. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 80 (2006) 9039-9052
24. Chiang C.M., and Roeder R.G. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 267 (1995) 531-536
25. Chiu Y.L., Cao H., Jacque J.M., Stevenson M., and Rana T.M. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J. Virol. 78 (2004) 2517-2529
26. Chun R.F., Semmes O.J., Neuveut C., and Jeang K.-T. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72 (1998) 2615-2629
27. Col E., Caron C., Seigneurin-Berny D., Gracia J., Favier A., and Khochbin S. The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J. Biol. Chem. 276 (2001) 28179-28184
28. Col E., Caron C., Chable-Bessia C., Legube G., Gazzeri S., Komatsu Y., Yoshida M., Benkirane M., Trouche D., and Khochbin S. HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. EMBO J. 24 (2005) 2634-2645
29. Copeland K.F. Modulation of HIV-1 transcription by cytokines and chemokines. Mini. Rev. Med. Chem. 5 (2005) 1093-1101
30. Creaven M., Hans F., Mutskov V., Col E., Caron C., Dimitrov S., and Khochbin S. Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. Biochemistry 38 (1999) 8826-8830
31. Cujec T.P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D.O., and Peterlin B.M. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11 (1997) 2645-2657
32. Dahmus M.E. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271 (1996) 19009-19012
33. Demarchi F., d'Adda di Fagagna F., Falaschi A., and Giacca M. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70 (1996) 4427-4437
34. Demarchi F., Gutierrez M.I., and Giacca M. Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J. Virol. 73 (1999) 7080-7086
35. Deng L., de la Fuente C., Fu P., Wang L., Donnelly R., Wade J.D., Lambert P., Li H., Lee C.G., and Kashanchi F. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 277 (2000) 278-295
36. Deng L., Ammosova T., Pumfery A., Kashanchi F., and Nekhai S. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter. J. Biol. Chem. 277 (2002) 33922-33929
37. Dokmanovic M., and Marks P.A. Prospects: Histone deacetylase inhibitors. J. Cell. Biochem. 96 (2005) 293-304
38. Dorr A., Kiermer V., Pedal A., Rackwitz H.R., Henklein P., Schubert U., Zhou M.M., Verdin E., and Ott M. Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J. 21 (2002) 2715-2723
39. el Kharroubi A., and Martin M.A. cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16 (1996) 2958-2966
40. el Kharroubi A., and Verdin E. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269 (1994) 19916-19924
41. Endo-Munoz L., Warby T., Harrich D., and McMillan N.A. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription. Virol. J. 2 (2005) 17
42. Fan H.Y., He X., Kingston R.E., and Narlikar G.J. Distinct strategies to make nucleosomal DNA accessible. Mol. Cell 11 (2003) 1311-1322
43. Fujinaga K., Irwin D., Huang Y., Taube R., Kurosu T., and Peterlin B.M. Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol. 24 (2004) 787-795
44. Garber M.E., Wei P., KewalRamani V.N., Mayall T.P., Herrmann C.H., Rice A.P., Littman D.R., and Jones K.A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12 (1998) 3512-3527
45. Garber M.E., Mayall T.P., Suess E.M., Meisenhelder J., Thompson N.E., and Jones K.A. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 20 (2000) 6958-6969
46. Garcia-Martinez L.F., Ivanov D., and Gaynor R.B. Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. J. Biol. Chem. 272 (1997) 6951-6958
47. Garcia-Martinez L.F., Mavankal G., Neveu J.M., Lane W.S., Ivanov D., and Gaynor R.B. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16 (1997) 2836-2850
48. Gatignol A., and Jeang K.-T. Tat as a transcriptional activator and a potential therapeutic target for HIV-1. In: Jeang K.-T. (Ed). "Advances in Pharmacology" (2000), Academic Press, San Diego, CA, USA and London, UK 209-227
49. Gibbons R.J. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum. Mol. Genet. 14 (2005) R85-R92 (Spec. No. 1)
50. Gold M.O., Yang X., Herrmann C.H., and Rice A.P. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo. J. Virol. 72 (1998) 4448-4453
51. Henderson A., Holloway A., Reeves R., and Tremethick D.J. Recruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 24 (2004) 389-397
52. Herrmann C.H., and Rice A.P. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197 (1993) 601-608
53. Herrmann C.H., and Rice A.P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69 (1995) 1612-1620
54. Hetzer C., Dormeyer W., Schnolzer M., and Ott M. Decoding Tat: The biology of HIV Tat posttranslational modifications. Microbes Infect. 7 (2005) 1364-1369
55. Hottiger M.O., and Nabel G.J. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J. Virol. 72 (1998) 8252-8256
56. Isel C., and Karn J. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. J. Mol. Biol. 290 (1999) 929-941
57. Ivanov D., Kwak Y.T., Guo J., and Gaynor R.B. Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol. 20 (2000) 2970-2983
58. Jeang K.-., Berkhout B., and Berkhout B. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps. J. Biol. Chem. 267 (1992) 17891-17899
59. Jeang K.-T., Chun R., Lin N.H., Gatignol A., Glabe C.G., and Fan H. In vitro and in vivo binding of human immunodeficiency virus type 1 tat protein and Sp1 transcription factor. J. Virol. 67 (1993) 6224-6233
60. Jordan A., Defechereux P., and Verdin E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20 (2001) 1726-1738
61. Jordan A., Bisgrove D., and Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22 (2003) 1868-1877
62. Kaehlcke K., Dorr A., Hetzer-Egger C., Kiermer V., Henklein P., Schnoelzer M., Loret E., Cole P.A., Verdin E., and Ott M. Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol. Cell 12 (2003) 167-176
63. Kamine J., and Chinnadurai G. Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J. Virol. 66 (1992) 3932-3936
64. Kamine J., Subramanian T., and Chinnadurai G. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA 88 (1991) 8510-8514
65. Kamine J., Elangovan B., Subramanian T., Coleman D., and Chinnadurai G. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 216 (1996) 357-366
66. Karn J. Tackling Tat. J. Mol. Biol. 293 (1999) 235-254
67. Kashanchi F., Piras G., Radonovich M.F., Duvall J.F., Fattaey A., Chiang C.-M., Roeder R.G., and Brady J.N. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 367 (1994) 295-299
68. Keen N.J., Gait M.J., and Karn J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA 93 (1996) 2505-2510
69. Kiernan R.E., Vanhulle C., Schiltz L., Adam E., Xiao H., Maudoux F., Calomme C., Burny A., Nakatani Y., Jeang K.T., Benkirane M., and Van Lint C. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18 (1999) 6106-6118
70. Kim Y.K., Bourgeois C.F., Isel C., Churcher M.J., and Karn J. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol. Cell. Biol. 22 (2002) 4622-4637
71. Kuppuswamy M., Subramanian T., Srinivasan A., and Chinnadurai G. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17 (1989) 3551-3561
72. Kwak Y.T., Guo J., Prajapati S., Park K.J., Surabhi R.M., Miller B., Gehrig P., and Gaynor R.B. Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties. Mol. Cell 11 (2003) 1055-1066
73. Lewinski M.K., Bisgrove D., Shinn P., Chen H., Hoffmann C., Hannenhalli S., Verdin E., Berry C.C., Ecker J.R., and Bushman F.D. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 79 (2005) 6610-6619
74. Liu J., Perkins N.D., Schmid R.M., and Nabel G.J. Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66 (1992) 3883-3887
75. Lusic M., Marcello A., Cereseto A., and Giacca M. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J. 22 (2003) 6550-6561
76. Mahmoudi T., Parra M., Vries R.G., Kauder S.E., Verrijzer C.P., Ott M., and Verdin E. The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J. Biol. Chem. 281 (2006) 19960-19968
77. Mancebo H.S., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Peng J., Blau C., Hazuda D., Price D., and Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11 (1997) 2633-2644
78. Marzio G., Tyagi M., Gutierrez M.I., and Giacca M. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA 95 (1995) 13519-13524
79. McMillan N.A., Chun R.F., Siderovski D.P., Galabru J., Toone W.M., Samuel C.E., Mak T.W., Hovanessian A.G., Jeang K.-T., and Williams B.R.G. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA dependent kinase, PKR. Virology 213 (1995) 413-424
80. Michels A.A., Nguyen V.T., Fraldi A., Labas V., Edwards M., Bonnet F., Lania L., and Bensaude O. MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner. Mol. Cell. Biol. 23 (2003) 4859-4869
81. Mujtaba S., He Y., Zeng L., Farooq A., Carlson J.E., Ott M., Verdin E., and Zhou M.M. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell 9 (2002) 575-586
82. Narlikar G.J., Fan H.Y., and Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 (2002) 475-487
83. Noonan D., and Albini A. From the outside in: Extracellular activities of HIV Tat. In: Jeang K.-T. (Ed). "Advances in Pharmacology" (2002), Academic Press, San Diego, CA, USA and London, U.K 229-250
84. Ott D.E. Cellular proteins in HIV virions. Rev. Med. Virol. 7 (1997) 167-180
85. Ott M., Schnolzer M., Garnica J., Fischle W., Emiliani S., Rackwitz H.R., and Verdin E. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol. 9 (1999) 1489-1492
86. Pagans S., Pedal A., North B.J., Kaehlcke K., Marshall B.L., Dorr A., Hetzer-Egger C., Henklein P., Frye R., McBurney M.W., Hruby H., Jung M., et al. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 3 (2005) e41
87. Pagtakhan A.S., and Tong-Starksen S.E. Interactions between Tat of HIV-2 and transcription factor Sp1. Virology 238 (1997) 221-230
88. Pazin M.J., Sheridan P.L., Cannon K., Cao Z., Keck J.G., Kadonaga J.T., and Jones K.A. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10 (1996) 37-49
89. Peng J., Zhu Y., Milton J.T., and Price D.H. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12 (1998) 755-762
90. Pereira L.A., Bentley K., Peeters A., Churchill M.J., and Deacon N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28 (2000) 663-668
91. Ping Y.H., and Rana T.M. Tat-associated kinase (P-TEFb): A component of transcription preinitiation and elongation complexes. J. Biol. Chem. 274 (1999) 7399-7404
92. Ping Y.H., and Rana T.M. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem. 276 (2001) 12951-12958
93. Ping Y.H., Chu C.Y., Cao H., Jacque J.M., Stevenson M., and Rana T.M. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. Retrovirology 1 (2004) 46
94. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20 (2000) 2629-2634
95. Pumfery A., Deng L., Maddukuri A., de la Fuente C., Li H., Wade J.D., Lambert P., Kumar A., and Kashanchi F. Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr. HIV Res. 1 (2003) 343-362
96. Quivy V., and Van Lint C. Diversity of acetylation targets and roles in transcriptional regulation: The human immunodeficiency virus type 1 promoter as a model system. Biochem. Pharmacol. 64 (2002) 925-934
97. Raha T., Cheng S.W., and Green M.R. HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol. 3 (2005) e44
98. Rana T.M., and Jeang K.-T. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Arch. Biochem. Biophys. 365 (1999) 175-185
99. Rohr O., Marban C., Aunis D., and Schaeffer E. Regulation of HIV-1 gene transcription: From lymphocytes to microglial cells. J. Leukoc. Biol. 74 (2003) 736-749
100. Roof P., Ricci M., Genin P., Montano M.A., Essex M., Wainberg M.A., Gatignol A., and Hiscott J. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology 296 (2002) 77-83
101. Sapountzi V., Logan I.R., and Robson C.N. Cellular functions of TIP60. Int. J. Biochem. Cell Biol. 38 (2006) 1496-1509
102. Schroder A.R., Shinn P., Chen H., Berry C., Ecker J.R., and Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110 (2002) 521-529
103. Sengupta N., and Seto E. Regulation of histone deacetylase activities. J. Cell. Biochem. 93 (2004) 57-67
104. Sheridan P.L., Sheline C.T., Cannon K., Voz M.L., Pazin M.J., Kadonaga J.T., and Jones K.A. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9 (1995) 2090-2104
105. Sheridan P.L., Mayall T.P., Verdin E., and Jones K.A. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev. 11 (1997) 3327-3340
106. Treand C., du Chene I., Bres V., Kiernan R., Benarous R., Benkirane M., and Emiliani S. Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J. 25 (2006) 1690-1699
107. Van Lint C. Role of chromatin in HIV-1 transcriptional regulation. In: Jeang K.-T. (Ed). "Advances in Pharmacology" (2002), Academic Press, San Diego, CA, USA and London, U.K 121-160
108. Van Lint C., Ghysdael J., Paras Jr. P., Burny A., and Verdin E. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol. 68 (1994) 2632-2648
109. Van Lint C., Emiliani S., Ott M., and Verdin E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15 (1996) 1112-1120
110. Varga-Weisz P.D., and Becker P.B. Regulation of higher-order chromatin structures by nucleosome-remodelling factors. Curr. Opin. Genet. Dev. 16 (2006) 151-156
111. Verdin E. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J. Virol. 65 (1991) 6790-6799
112. Verdin E., Paras J., and Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12 (1993) 3249-3259
113. Verdone L., Caserta M., and Di Mauro E. Role of histone acetylation in the control of gene expression. Biochem. Cell Biol. 83 (2005) 344-353
114. Veschambre P., Simard P., and Jalinot P. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J. Mol. Biol. 250 (1995) 169-180
115. Veschambre P., Roisin A., and Jalinot P. Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB. J. Gen. Virol. 78 (1997) 2235-2245
116. Wada T., Takagi T., Yamaguchi Y., Ferdous A., Imai T., Hirose S., Sugimoto S., Yano K., Hartzog G.A., Winston F., Buratowski S., and Handa H. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes 12 (1998) 343-356
117. Wada T., Takagi T., Yamaguchi Y., Watanabe D., and Handa H. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17 (1998) 7395-7403
118. Wei P., Garber M.E., Fang S.M., Fischer W.H., and Jones K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92 (1998) 451-462
119. Weissman J.D., Brown J.A., Howcroft T.K., Hwang J., Chawla A., Roche P.A., Schiltz L., Nakatani Y., and Singer D.S. HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. Proc. Natl. Acad. Sci. USA 95 (1998) 11601-11606
120. Widlak P., Gaynor R.B., and Garrard W.T. In vitro chromatin assembly of the HIV-1 promoter. ATP-dependent polar repositioning of nucleosomes by Sp1 and NFkappaB. J. Biol. Chem. 272 (1997) 17654-17661
121. Wu-Baer F., Lane W.S., and Gaynor R.B. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. J. Mol. Biol. 277 (1998) 179-197
122. Yamada T., Yamaguchi Y., Inukai N., Okamoto S., Mura T., and Handa H. P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation. Mol. Cell 21 (2006) 227-237
123. Yamaguchi Y., Takagi T., Wada T., Yano K., Furuya A., Sugimoto S., Hasegawa J., and Handa H. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97 (1999) 41-51
124. Yamaguchi Y., Inukai N., Narita T., Wada T., and Handa H. Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol. Cell. Biol. 22 (2002) 2918-2927
125. Yamamoto T., and Horikoshi M. Novel substrate specificity of the histone acetyltransferase activity of HIV-1-Tat interactive protein Tip60. J. Biol. Chem. 272 (1997) 30595-30598
126. Yang X., Herrmann C.H., and Rice A.P. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70 (1996) 4576-4584
127. Yang X., Gold M.O., Tang D.N., Lewis D.E., Aguilar-Cordova E., Rice A.P., and Herrmann C.H. TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA 94 (1997) 12331-12336
128. Yang X.J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32 (2004) 959-976
129. Yedavalli V.S., Benkirane M., and Jeang K.T. Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1. J. Biol. Chem. 278 (2003) 6404-6410
130. Yik J.H., Chen R., Nishimura R., Jennings J.L., Link A.J., and Zhou Q. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol. Cell 12 (2003) 971-982
131. Zhou M., Halanski M.A., Radonovich M.F., Kashanchi F., Peng J., Price D.H., and Brady J.N. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20 (2000) 5077-5086
132. Zhou M., Nekhai S., Bharucha D.C., Kumar A., Ge H., Price D.H., Egly J.M., and Brady J.N. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription. J. Biol. Chem. 276 (2001) 44633-44640
133. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M.B., and Price D.H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11 (1997) 2622-2632
134. Zorio D.A., and Bentley D.L. Transcription elongation: The 'Foggy' is liftingellipsis. Curr. Biol. 11 (2001) R144-R146